FRANK A AGNONE MD NPI 1891783411

NPI Details

Frank A Agnone, MD is an internal medicine in Phoenix, AZ with 38 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Frank A Agnone, MD NPI is 1891783411. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1988

The provider's business location address is:

345 E VIRGINIA AVE
PHOENIX, AZ
ZIP 85004
Phone: (602) 258-5545
Fax: (602) 258-5545

The NPI 1891783411 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Annual alcohol misuse screening, 15 minutes (HCPCS:G0442)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Hemoglobin a1c level (HCPCS:83036)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg (HCPCS:J7613)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Removal of impacted ear wax (HCPCS:69210)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Inhalation treatment for pneumonia (HCPCS:94642)
• Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS:94060)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Intravenous injection, bebtelovimab, includes injection and post administration monitoring (HCPCS:M0222)
• Evaluation of use of breathing device (HCPCS:94664)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow (HCPCS:G0181)
• Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and (HCPCS:G0180)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Influenza vaccine, quadrivalent derived from cell cultures (HCPCS:90756)
• Photography of the retina (HCPCS:92250)
• Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or (HCPCS:G2212)
• Injection, garamycin, gentamicin, up to 80 mg (HCPCS:J1580)
• Measurement of liver stiffness (HCPCS:91200)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Intravenous infusion, sotrovimab, includes infusion and post administration monitoring (HCPCS:M0247)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Transitional care management services for problem of high complexity (HCPCS:99496)

The enumeration date for this NPI number is 10/7/2005 and was last updated on 8/1/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: